Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), bought 10,678,808 shares at $19.00 ($5.0M) on 2022-01-11, disclosed to the SEC on 2022-01-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,415,650 | $0 | 0.0% |
| 2 | $19.00 | 263,158 | $5.0M | 100.0% |
| Total | $0.47 avg | 10,678,808 | $5.0M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |